"Notre établissement public de santé propose des consultations médicales spécialisées dans différents domaines. La direction, les médecins et l'ensemble des professionnels mettent tout en œuvre pour vous faire bénéficier de soins de qualité et des meilleurs services possibles. Le Centre Hospitalier de Cholet est certifié pour la 4ème fois par la HAS, depuis novembre 2016. Le laboratoire de biologie médicale est accrédité pour la qualité de ses prestations. Pour connaître le numéro du service que vous recherchez, cliquez sur toutes nos coordonnées ou bien rendez-vous sur notre site internet."

During the past decade, CH de Cholet; oncologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Cholet; oncologie" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CH de Cholet; oncologie" are "Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "CH de Cholet; oncologie" in a lesser frequency.

Most popular intervention types in "CH de Cholet; oncologie" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Dose-dense Doxorubicin or dose-dense Epirubicin" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH de Cholet; oncologie" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CH de Cholet; oncologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CH de Cholet; oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH de Cholet; oncologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".